Skip to main content

Cost-Effectiveness Analysis 2.0.

Publication ,  Journal Article
Neumann, PJ; Sanders, GD
Published in: N Engl J Med
January 19, 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

January 19, 2017

Volume

376

Issue

3

Start / End Page

203 / 205

Location

United States

Related Subject Headings

  • United States
  • Quality-Adjusted Life Years
  • Humans
  • Health Care Rationing
  • Health Care Costs
  • Guidelines as Topic
  • General & Internal Medicine
  • Cost-Benefit Analysis
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Neumann, P. J., & Sanders, G. D. (2017). Cost-Effectiveness Analysis 2.0. N Engl J Med, 376(3), 203–205. https://doi.org/10.1056/NEJMp1612619
Neumann, Peter J., and Gillian D. Sanders. “Cost-Effectiveness Analysis 2.0.N Engl J Med 376, no. 3 (January 19, 2017): 203–5. https://doi.org/10.1056/NEJMp1612619.
Neumann PJ, Sanders GD. Cost-Effectiveness Analysis 2.0. N Engl J Med. 2017 Jan 19;376(3):203–5.
Neumann, Peter J., and Gillian D. Sanders. “Cost-Effectiveness Analysis 2.0.N Engl J Med, vol. 376, no. 3, Jan. 2017, pp. 203–05. Pubmed, doi:10.1056/NEJMp1612619.
Neumann PJ, Sanders GD. Cost-Effectiveness Analysis 2.0. N Engl J Med. 2017 Jan 19;376(3):203–205.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

January 19, 2017

Volume

376

Issue

3

Start / End Page

203 / 205

Location

United States

Related Subject Headings

  • United States
  • Quality-Adjusted Life Years
  • Humans
  • Health Care Rationing
  • Health Care Costs
  • Guidelines as Topic
  • General & Internal Medicine
  • Cost-Benefit Analysis
  • 42 Health sciences
  • 32 Biomedical and clinical sciences